Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private equity firm ARCHIMED, which now holds a majority stake. BOCA RATON, Fla., July 30, 2025 /PRNewswire/ -- Arkstone,...
Hence then, the article about archimed acquires a majority stake in arkstone forging a powerful partnership to accelerate global healthcare innovation and dominate the emerging ai driven clinical decision support market was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ARCHIMED Acquires a Majority Stake in Arkstone, Forging a Powerful Partnership to Accelerate Global Healthcare Innovation And Dominate the Emerging AI-Driven Clinical Decision Support Market )
Also on site :
- E.J. WARD INC. APPOINTS NEW CTO AND CFO TO DRIVE GROWTH AND INNOVATION, ENHANCING MARKET PRESENCE AND TECHNOLOGY LEADERSHIP
- Portfolio BI, Decathlon Capital Partners Reach Agreement on Significant Investment to Strengthen Platform's AI Capabilities
- TCL Electronics (01070.HK) Included in Hang Seng Composite LargeCap & MidCap Index and Other Authoritative Indices